Company Email Format Management

Citryll

Biotechnology Research Ae, Noord-brabant, Nl 32 employees

Employees: 32
Contacts: 4
Emails: 4

citryll.com LinkedIn Crunchbase

Citryll Overview

Headquarters: Ae, Noord-brabant, Nl
Website: citryll.com
Industry: Biotechnology Research
Employees: 32
Founded: 2015
Funding: 89.7M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immunology Therapeutics development Neutrophil Extracellular Traps Inflammatory diseases Antibody development Rheumatoid Arthritis Hidradenitis Suppurativa

About Citryll

Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a precise and powerful ability to control NETs and NETosis. Citryll is initially developing CIT-013 as a novel drug for rheumatoid arthritis and hidradenitis suppurativa, which may serve as enabling indications for a wide spectrum of inflammatory diseases. The initial clinical trials with CIT-013 are expected to provide the foundation for a new treatment paradigm.

Citryll Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage

Citryll Org Chart

Sample employees and titles

Name	Title	Location	Contact
Fiona Maclaughlin		United Kingdom	Email
Maarten Kraan		Utrecht, Netherlands	Email
Katerina Pardali	Expert in Translational Medicine and Biomarker Strategy in Early Clinical Trials / Ph.d. in Mollecular Cell Biology, Ludvig Institute for Cancer	Copenhagen, Capital Region of Denmark, Denmark	Email
Tim Schenk	Cbo Citryll	Amsterdam, North Holland, Netherlands	Email